content
Alpha-1 adrenergic receptor
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alpha-1_adrenergic_receptor" .
The alpha-1 adrenergic receptor (α1 -AR) is an adrenergic receptor with the primary effect of vasoconstriction .
Effect
The α1 receptor has several, general, functions in common with other α-receptors, but also has specific effects.
General
Common (or still unspecified) effects include:
Specific
The primary effect is on smooth muscle , which mainly constrict. However, there are other functions as well.
Smooth muscle
In smooth muscle of blood vessels the principal effect is vasoconstriction . Blood vessels with α1 receptors are present in the skin , the sphincters [4] of gastrointestinal system , kidney (renal artery )[5] and brain .[6] During the fight-or-flight response vasoconstriction results in the decreased blood flow to these organs. This accounts for an individual's skin appearing pale when frightened.
It also induces contraction of the urinary bladder [7] [8] , although this effect is minor compared to the relaxing effect of β-2 adrenergic receptors . In other words, the overall effect of sympathetic stimuli on the bladder is relaxation, in order to delay micturition during stress.
Other effects are on smooth muscle are contraction in:
In a few areas the result on smooth muscle is relaxation. These include:
Other
Activate mitogenic responses and regulate growth and proliferation of many cells.
Activity During Exercise
During exercise these alpha-1 receptors can be selectively blocked by sympathetic nervous activity, allowing the beta-2 receptors (which mediate vasodilation) to dominate. Note that only the alpha-1 receptors in exercising muscle will be blocked. Resting muscle will not have its alpha-1 receptors blocked, and hence the overall effect there will be alpha-1 mediated vasocontriction.
Mechanism
Alpha1 -adrenergic receptors are members of the G protein-coupled receptor superfamily. Upon activation, a heterotrimeric G protein , Gq , activates phospholipase C (PLC), which causes an increase in IP3 and calcium . This triggers all other effects.
Agonists
Agonists include:
* denotes selective agonists to the receptor.
Noradrenaline has higher receptor affinity than has adrenaline, which, in turn has much higher affinity than isoprenaline.[4]
Antagonists
Antagonists are various alpha blockers :
* denotes selective antagonists to the receptor.
Subtypes
There are 3 α1 -AR subtypes: alpha-1A , -1B and -1D , all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation.
See also
References
^ Woodman OL, Vatner SF (1987). "Coronary vasoconstriction mediated by α1 - and α2 -adrenoceptors in conscious dogs ". Am. J. Physiol. 253 (2 Pt 2): H388–93. PMID 2887122 .
^ Elliott J (1997). "Alpha-adrenoceptors in equine digital veins: evidence for the presence of both α1 and α2 -receptors mediating vasoconstriction". J. Vet. Pharmacol. Ther. 20 (4): 308–17. doi :10.1046/j.1365-2885.1997.00078.x . PMID 9280371 .
^ Sagrada A, Fargeas MJ, Bueno L (1987). "Involvement of α1 and α2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut 28 (8): 955–9. doi :10.1136/gut.28.8.955 . PMID 2889649 .
^ a b c d e f g h i Rang, H. P. (2003). Pharmacology . Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4 . Page 163
^ Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA (1981). "Renal α1 and α2 adrenergic receptors: biochemical and pharmacological correlations ". J. Pharmacol. Exp. Ther. 219 (2): 400–6. PMID 6270306 .
^ Circulation & Lung Physiology I M.A.S.T.E.R. Learning Program, UC Davis School of Medicine
^ a b c d e f g Fitzpatrick, David; Purves, Dale; Augustine, George (2004). "Table 20:2", Neuroscience , Third Edition, Sunderland, Mass: Sinauer. ISBN 0-87893-725-0 .
^ Chou EC, Capello SA, Levin RM, Longhurst PA (2003). "Excitatory α1 -adrenergic receptors predominate over inhibitory β-receptors in rabbit dorsal detrusor". J. Urol. 170 (6 Pt 1): 2503–7. doi :10.1097/01.ju.0000094184.97133.69 . PMID 14634460 .
^ Morton JS, Daly CJ, Jackson VM, McGrath JC (2007). "Alpha1A -adrenoceptors mediate contractions to phenylephrine in rabbit penile arteries". Br. J. Pharmacol. 150 (1): 112–20. doi :10.1038/sj.bjp.0706956 . PMID 17115072 .
^ a b Walter F., PhD. Boron. Medical Physiology: A Cellular And Molecular Approaoch . Elsevier/Saunders. ISBN 1-4160-2328-3 . Page 787
Transmembrane receptor : G protein-coupled receptors
Class A : Rhodopsin like
GPR (
1 ,
3 ,
4 ,
6 ,
12 ,
15 ,
17 ,
18 ,
19 ,
20 ,
21 ,
22 ,
23 ,
25 ,
26 ,
27 ,
31 ,
32 ,
33 ,
34 ,
35 ,
37 ,
39 ,
42 ,
44 ,
45 ,
50 ,
52 ,
55 ,
61 ,
62 ,
63 ,
65 ,
68 ,
75 ,
77 ,
78 ,
79 ,
82 ,
83 ,
84 ,
85 ,
87 ,
88 ,
92 ,
101 ,
103 ,
119 ,
120 ,
132 ,
135 ,
139 ,
141 ,
142 ,
146 ,
148 ,
149 ,
150 ,
151 ,
152 ,
153 ,
160 ,
161 ,
162 ,
171 ,
172 ,
173 ,
174 ,
176 ,
177 ,
182 )
Adenosine (
A1 ,
A2a ,
A2b ,
A3 ) •
P2Y (
1 ,
2 ,
4 ,
5 ,
6 ,
8 ,
9 ,
10 ,
11 ,
12 ,
13 ,
14 )
Other
Acetylcholine (
M1 ,
M2 ,
M3 ,
M4 ,
M5 ) •
Adrenomedullin •
Anaphylatoxin (
C3a ,
C5a ) •
Angiotensin (
1 ,
2 ) •
Apelin •
Bile acid •
Bombesin (
BRS3 ,
GRPR ,
NMBR ) •
Bradykinin (
B1 ,
B2 ) •
Cannabinoid (
CB1 ,
CB2 ) •
Chemokine •
Cholecystokinin (
A ,
B ) •
Dopamine (
D1 ,
D2 ,
D3 ,
D4 ,
D5 ) •
EBI2 •
Endothelin (
A ,
B ) •
Estrogen •
Formyl peptide (
1 ,
L1 ,
L2 ) •
Free fatty acid (
1 ,
2 ,
3 ,
4 ) •
FSH •
Galanin (
1 ,
2 ,
3 ) •
Gonadotropin-releasing hormone (
1 ,
2 ) •
Ghrelin •
Histamine (
H1 ,
H2 ,
H3 ,
H4 ) •
Kisspeptin •
Luteinizing hormone/choriogonadotropin •
Lysophospholipid (
1 ,
2 ,
3 ,
4 ,
5 ,
6 ,
7 ,
8 ) •
MAS (
1 ,
1L ,
D ,
E ,
F ,
G ,
X1 ,
X2 ,
X3 ,
X4 ) •
Melanocortin (
1 ,
2 ,
3 ,
4 ,
5 ) •
MCHR (
1 ,
2 ) •
Melatonin (
1A ,
1B ) •
Motilin •
Neuromedin (
B ,
U (
1 ,
2 )) •
Neurotensin (
1 ,
2 ) •
Opioid (
Delta ,
Kappa ,
Mu ,
Nociceptin , but not
Sigma ) •
Olfactory •
Opsin (
3 ,
4 ,
5 ,
1LW ,
1MW ,
1SW ,
RGR ,
RRH ) •
Orexin (
1 ,
2 ) •
Oxytocin •
Oxoglutarate •
PAF •
Prokineticin (
1 ,
2 ) •
Prolactin-releasing peptide •
Protease-activated (
1 ,
2 ,
3 ,
4 ) •
Relaxin (
1 ,
2 ,
3 ,
4 ) •
Somatostatin (
1 ,
2 ,
3 ,
4 ,
5 ) •
SREB •
Succinate •
TAAR (
1 ,
2 ,
3 ,
5 ,
6 ,
8 ,
9 ) •
Tachykinin (
1 ,
2 ,
3 ) •
Thyrotropin •
Thyrotropin-releasing hormone •
Urotensin-II •
Vasopressin (
1A ,
1B ,
2 )
Class B : Secretin like
GPR (
56 ,
64 ,
97 ,
98 ,
110 ,
111 ,
112 ,
113 ,
114 ,
115 ,
116 ,
123 ,
124 ,
125 ,
126 ,
128 ,
133 ,
143 ,
144 ,
157 )
Other
Brain-specific angiogenesis inhibitor (
1 ,
2 ,
3 ) •
Cadherin (
1 ,
2 ,
3 ) •
Calcitonin •
CALCRL •
CD97 •
Corticotropin-releasing hormone (
1 ,
2 ) •
EMR (
1 ,
2 ,
3 ) •
Glucagon (
GR ,
GIPR ,
GLP1R ,
GLP2R ) •
Growth hormone releasing hormone •
PACAPR1 •
GPR •
Latrophilin (
1 ,
2 ,
3 ,
ELTD1 ) •
Parathyroid hormone (
1 ,
2 ) •
Secretin •
Vasoactive intestinal peptide (
1 ,
2 )
Class C : Metabotropic
glutamate / pheromone
TAS1R (
1 ,
2 ,
3 ) •
TAS2R (
1 ,
3 ,
4 ,
5 ,
8 ,
9 ,
10 ,
12 ,
13 ,
14 ,
16 ,
38 ,
39 ,
40 ,
41 ,
43 ,
44 ,
45 ,
46 ,
47 ,
48 ,
49 ,
50 )
Other
Calcium-sensing receptor •
GABA B (
1 ,
2 ) •
Glutamate receptor (
Metabotropic glutamate (
1 ,
2 ,
3 ,
4 ,
5 ,
6 ,
7 ,
8 )) •
GPRC6A •
GPR (
156 ,
158 ,
179 ) •
RAIG (
1 ,
2 ,
3 ,
4 )
Frizzled / Smoothened
© jGames.co.uk 2007 (some content from Wikipedia under GDL )
!-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->